CRDF 8-K: SEC filing

Cardiff Oncology

Filed with the SEC on · accession 0001193125-26-458500

CRDF filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -4.9% by the first close after the filing.

Summary of the filing

Cardiff Oncology issued a press release announcing a business update and financial results for the third quarter ended September 30, 2026.

Key details

RegistrantCardiff Oncology, Inc.
President and chief executive officerMani Mohindru

How CRDF stock reacted

Close before

$0.77

Nov 11, 2026

First close after

-4.93%

$0.73

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CRDF, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CRDF?

Click here

Frequently asked questions

What did CRDF file with the SEC on Nov 12, 2026?

CRDF filed a 8-K (SEC filing). Cardiff Oncology issued a press release announcing a business update and financial results for the third quarter ended September 30, 2026.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did CRDF stock react to this filing?

CRDF closed at $0.77 before the filing and $0.73 on Nov 12, 2026 (-4.93%).

Other CRDF SEC filings

Get alerts when CRDF files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days